Exploring anti-malarial potential of FDA approved drugs: an in silico approach

被引:0
作者
Gayatri Ramakrishnan
Nagasuma Chandra
Narayanaswamy Srinivasan
机构
[1] Indian Institute of Science,Indian Institute of Science Mathematics Initiative
[2] Indian Institute of Science,Department of Biochemistry
[3] Indian Institute of Science,Molecular Biophysics Unit
[4] Brigham and Women’s Hospital and Harvard Medical School,Division of Genetics, Department of Medicine
来源
Malaria Journal | / 16卷
关键词
Antimalarial agents; Drug repurposing; Drug targets; Sequence analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 247 条
[1]  
Valderramos SG(2006)Transporters involved in resistance to antimalarial drugs Trends Pharmacol Sci 27 594-601
[2]  
Fidock DA(2010)Artemisinin resistance: current status and scenarios for containment Nat Rev Microbiol 8 272-280
[3]  
Dondorp AM(2011)Pitfalls in new artemisinin-containing antimalarial drug development Trends Parasitol 27 82-90
[4]  
Yeung S(2011)Drug repositioning in the treatment of malaria and TB Future Med Chem 3 1413-1426
[5]  
White L(2011)Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets Science 333 724-729
[6]  
Nguon C(2013)Drug repositioning as a route to anti-malarial drug discovery: preliminary investigation of the in vitro anti-malarial efficacy of emetine dihydrochloride hydrate Malar J 12 359-D543
[7]  
Day NP(2015)Antiprotozoal activity profiling of approved drugs: a starting point toward drug repositioning PLoS ONE 10 e0135556-4045
[8]  
Socheat D(2012)Global analysis of small molecule binding to related protein targets PLoS Comput Biol 8 e1002333-526
[9]  
Jambou R(2009)PlasmoDB: a functional genomic database for malaria parasites Nucleic Acids Res 37 D539-1508
[10]  
Le Bras J(2013)Global analysis of protein expression and phosphorylation of three stages of J Proteome Res 12 4028-1143